Bio Tech/Life SciencesHealthtechB2B1-5 employees
Bootstrapped Founder
Serial Entrepreneur
Female Founder
Exited FounderAbout
Biologics for metabolic diseases. Elangen, Inc., was founded in 2024 to advance therapeutics to safely treat, prevent, and reverse complications of metabolic disorders. Elangen's antibody-peptide conjugates were designed to break the inflammatory loops that underlie disease progression and drive pathologies of aging.
Products
Biologics for metabolic disease.
Elangen, Inc., was founded in 2024 to advance therapeutics to safely treat, prevent, and reverse complications of metabolic disorders. Elangen's antibody-peptide conjugates were designed to break the inflammatory loops that underlie disease progression and drive pathologies of aging.
Click to read more